Literature DB >> 7672129

Accumulation of cyclic ADP-ribose measured by a specific radioimmunoassay in differentiated human leukemic HL-60 cells with all-trans-retinoic acid.

K Takahashi1, I Kukimoto, K Tokita, K Inageda, S Inoue, K Kontani, S Hoshino, H Nishina, Y Kanaho, T Katada.   

Abstract

Cyclic adenosine diphosphoribose (cADPR) is a novel candidate for the mediator of Ca2+ release from intracellular Ca2+ stores. The formation of this cyclic nucleotide is catalyzed by not only Aplysia ADP-ribosyl cyclase but also an ecto-form enzyme of NAD+ glycohydrolase (NADase), which was previously identified as all-trans-retinoic acid (RA)-inducible CD38 in human leukemic HL-60 cells. In the present study, we developed a radioimmunoassay specific for cADPR, by which more than 100 fmol of cADPR could be detected without any interference by other nucleotides. The possible involvement of CD38 in the formation of cellular cADPR was investigated with the radioimmunoassay method. A marked increase in cellular cADPR was accompanied by all-trans-RA-induced differentiation of HL-60 cells. Moreover, a high level of cellular cADPR was observed in other leukemic cell lines, in which CD38 mRNA was expressed. Thus, CD38, which was initially identified as an NADase, appeared to be responsible for the formation of cellular cADPR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672129     DOI: 10.1016/0014-5793(95)00914-u

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  The CD38-cyclic ADP-ribose signaling system in insulin secretion.

Authors:  H Okamoto
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

2.  Identification of direct and indirect effectors of the transient receptor potential melastatin 2 (TRPM2) cation channel.

Authors:  Balázs Tóth; László Csanády
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

3.  Effect of estrogen upon cyclic ADP ribose metabolism: beta-estradiol stimulates ADP ribosyl cyclase in rat uterus.

Authors:  E N Chini; F G de Toledo; M A Thompson; T P Dousa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

4.  Ectocellular in vitro and in vivo metabolism of cADP-ribose in cerebellum.

Authors:  A De Flora; L Guida; L Franco; E Zocchi; M Pestarino; C Usai; C Marchetti; E Fedele; G Fontana; M Raiteri
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

5.  A novel cycling assay for cellular cADP-ribose with nanomolar sensitivity.

Authors:  Richard Graeff; Hon Cheung Lee
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

Review 6.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  A novel cycling assay for nicotinic acid-adenine dinucleotide phosphate with nanomolar sensitivity.

Authors:  Richard Graeff; Hon Cheung Lee
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

8.  Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.

Authors:  F Ikehata; J Satoh; K Nata; A Tohgo; T Nakazawa; I Kato; S Kobayashi; T Akiyama; S Takasawa; T Toyota; H Okamoto
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

9.  Transcription Factor Activation Profiles (TFAP) identify compounds promoting differentiation of Acute Myeloid Leukemia cell lines.

Authors:  Federica Riccio; Elisa Micarelli; Riccardo Secci; Giulio Giuliani; Simone Vumbaca; Giorgia Massacci; Luisa Castagnoli; Claudia Fuoco; Gianni Cesareni
Journal:  Cell Death Discov       Date:  2022-01-10

10.  Refinement of a radioreceptor binding assay for nicotinic acid adenine dinucleotide phosphate.

Authors:  Alexander M Lewis; Roser Masgrau; Sridhar R Vasudevan; Michiko Yamasaki; John S O'Neill; Clive Garnham; Kristin James; Andrew Macdonald; Mathias Ziegler; Antony Galione; Grant C Churchill
Journal:  Anal Biochem       Date:  2007-09-01       Impact factor: 3.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.